HIGHFDA DRUG
Lannett Company Recalls Niacin Tablets for Failed Dissolution
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.
NIACIN
Failed Dissolution